This report describes a usually mild syndrome, dubbed LICATS, affecting about three-quarters of CAR T-cell recipients.

The liver is critical to maintaining the functioning of the body as it processes nutrients from the diet, produces key ...

Genocury Biotech announces positive results from noval in vivo CD19 CAR-T therapy in relapsed/refractory diffuse large B-cell lymphoma: Shenzhen, China Friday, May 2, 2025, 15:00 ...

A patient with heavily pretreated relapsed/refractory diffuse large B-cell lymphoma achieved complete remission following ...

Olalekan O Oluwole, MD, MBBS, discussed a study on cytokine release syndrome and neurological events post axicabtagene ...

Watch how Beacon Discovery™, Bruker Cellular Analysis’s accessible, compact, and flexible platform, is redefining live single-cell functional analysis, bringing deeper biological insights to every lab ...

Discover foods that support nerve regeneration and repair damaged neural tissue. Learn how specific nutrients rebuild myelin ...

Regeneron’s bispecific antibody linvoseltamab, now branded as Lynozyfic, has received conditional approval from the European ...

Positive results of PARP inhibitor and CAR T-cell treatments highlight advances in research for neuroblastoma.

Runimotamab plus trastuzumab resulted in positive clinical activity and tolerability over runimotamab alone in patients with ...

Researchers from the Sant Pau Research Institute (IR Sant Pau), in collaboration with Sant Pau Hospital and the Josep Carreras Leukaemia Research Institute, have developed an innovative CAR-T cell ...